More than 110 stocks have been consecutively falling for 5 years. Institutions are paying high attention to these individual stocks.

The AI industry chain is advancing rapidly, and the ChiNext and the Sci-Tech Innovation Board Index have recently hit historical highs. However, in recent years, the market differentiation has been quite severe, with the prices of some individual stocks falling year after year, and even experiencing several consecutive years of decline. According to Data Treasure statistics, more than 110 individual stock prices have been falling for five consecutive years. In terms of the number of years of continuous decline, two film and television stocks, Ru Yi Film and ST Huayi, have both been falling for 11 years, while individual stocks such as Jin Yu Shares, JinRong Street, and Jin Yu Ji Dong have all been falling for 7 years. In terms of cumulative decline, the delisted Yanshi has the largest decline, with a cumulative decline of nearly 94%; ZhongGong Education ranks second, with a decline of over 94%. In addition, Jian Lang Hardware, ST Huayi, and other individual stocks have cumulative declines of over 90%, while Ru Yi Film, Kangtai Bio, Vanke A, ST Longda, and other individual stocks have cumulative declines of over 80%. In terms of market value, there are still 4 individual stocks with A-share market values exceeding 100 billion yuan, namely Mindray Medical, Shanxi Fenjiu, Jin Longyu, and Luzhou Laojiao. Among the stocks that institutions are paying close attention to, according to Data Treasure statistics, more than 20 stocks such as Shanxi Fenjiu, Mindray Medical, Luzhou Laojiao, and Shede Winery have been rated by 10 or more institutions, while 16 stocks such as Ru Yi Film, Zhibang Home, and JA Solar Technology have been rated by 5-9 institutions. The stock with the highest institutional attention is Shanxi Fenjiu, which has been rated by 33 institutions. Guosen Securities stated that in the short term, there is still pressure on scenarios and demand in 2026, channel inventory is at a high level, and the company will gradually release its operating pressure throughout the year, with revenue and net profit expected to decline. In the medium to long term, the company's product price ratio is outstanding, management is improving efficiency, and there is still room for nationalization and high-end development.